User contributions
- 17:37, 5 November 2017 (diff | hist) . . (+446) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 17:34, 5 November 2017 (diff | hist) . . (+204) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 17:33, 5 November 2017 (diff | hist) . . (+197) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 17:32, 5 November 2017 (diff | hist) . . (+234) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 17:27, 5 November 2017 (diff | hist) . . (+419) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 17:26, 5 November 2017 (diff | hist) . . (+216) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 17:20, 5 November 2017 (diff | hist) . . (+276) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 17:18, 5 November 2017 (diff | hist) . . (+172) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 17:16, 5 November 2017 (diff | hist) . . (+442) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 17:06, 5 November 2017 (diff | hist) . . (+197) . . m Pharmacovigilance (→ADVERSE EVENT REPORTING TIMELINES)
- 17:03, 5 November 2017 (diff | hist) . . (+377) . . m Pharmacovigilance (→Importance of Pharmacovigilance in Clinical Trials)
- 16:56, 5 November 2017 (diff | hist) . . (+335) . . m Pharmacovigilance (→Importance of Pharmacovigilance in Clinical Trials)
- 16:52, 5 November 2017 (diff | hist) . . (+447) . . Pharmacovigilance (→Importance of Pharmacovigilance in Clinical Trials)
- 16:49, 5 November 2017 (diff | hist) . . (+290) . . m Pharmacovigilance
- 16:48, 5 November 2017 (diff | hist) . . (+248) . . m Pharmacovigilance
- 16:47, 5 November 2017 (diff | hist) . . (-51) . . m Pharmacovigilance
- 16:35, 5 November 2017 (diff | hist) . . (+597) . . m Pharmacovigilance (→Importance of Pharmacovigilance in Clinical Trials)
- 16:32, 5 November 2017 (diff | hist) . . (+289) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:31, 5 November 2017 (diff | hist) . . (+231) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:30, 5 November 2017 (diff | hist) . . (+184) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:29, 5 November 2017 (diff | hist) . . (+186) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:28, 5 November 2017 (diff | hist) . . (+289) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:25, 5 November 2017 (diff | hist) . . (+287) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:24, 5 November 2017 (diff | hist) . . (+249) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:22, 5 November 2017 (diff | hist) . . (+273) . . m Pharmacovigilance (→"Pharmacovigilance in Clinical Practice" http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 16:14, 5 November 2017 (diff | hist) . . (+156) . . m Pharmacovigilance (→Pharmacovigilance activities)
- 10:20, 2 November 2017 (diff | hist) . . (-2) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 18:05, 20 October 2017 (diff | hist) . . (-53) . . m Pharmacovigilance (→Pharmacovigilance in Clinical Practice http://apps.who.int/medicinedocs/en/d/Js4893e/6.html#Js4893e.6)
- 17:26, 20 October 2017 (diff | hist) . . (-26) . . m Pharmacovigilance (→Why is Pharmacovigilance important?)
- 17:33, 11 October 2017 (diff | hist) . . (-27) . . m Pharmacovigilance (→Pharmacovigilance activities)
- 17:17, 11 October 2017 (diff | hist) . . (-1) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 17:15, 11 October 2017 (diff | hist) . . (-10) . . Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 11:49, 22 September 2017 (diff | hist) . . (+130) . . Nm userpage of Rahul Kakde (Creating userpage) (current)
